Active Ingredient: LEVODOPA
Proprietary Name: INBRIJA
Dosage Form; Route of Administration: POWDER; INHALATION
Strength: 42MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209184
Product Number: 001
Approval Date: Dec 21, 2018
Applicant Holder Full Name: MERZ PHARMACEUTICALS LLC A SUB OF MERZ THERAPEUTICS GMBH
Marketing Status:
Prescription
Patent and Exclusivity Information
